Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation email@example.com
SPECIAL REPORT #31
Top 20 Pharmaceutical Companies by Market Cap.
GlobalData, a London-based data provider to large industries, issued a report where it lists the new top 20 pharma companies by market capitalisation as of March 31, 2019.
The two major events in this list are:
- the emergence of Takeda in #16 position (#23 position in Q42018) following its $62 billion acquisition of Shire
- the disappearance of Biogen (now at $41 billion market cap) after the failure of aducanumab as a potential treatment of Alzheimer’s disease.
The list includes ten US based companies with Johnson & Johnson leading the pack, eight European based companies with Roche slightly ahead of Novartis, CSL an Australian company and Takeda a Japanese company.
This Q1 2019 ranking will be profoundly modified following the complete integration of Celgene, currently #18 into Bristol-Myers Squibb and Allergan, #20 into AbbVie by year end and thus open the door to new entries.
October 10, 2019
This document has been prepared by btobioinnovation and is provided to you for information purposes only. The information contained in this document has been obtained from sources that btobioinnovation believes are reliable but btobioinnovation does not warrant that it is accurate or complete. The views presented in this document are those of btobioinnovation’s editor at the time of writing and are subject to change. btobioinnovation has no obligation to update its opinions or the information in this document.